Article Search
검색
검색 팝업 닫기

Metrics

Help

  • 1. Aims and Scope

    Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE

  • 2. Editorial Board

    Editor-in-Chief + MORE

    Editor-in-Chief
    Yong Chan Lee Professor of Medicine
    Director, Gastrointestinal Research Laboratory
    Veterans Affairs Medical Center, Univ. California San Francisco
    San Francisco, USA

    Deputy Editor

    Deputy Editor
    Jong Pil Im Seoul National University College of Medicine, Seoul, Korea
    Robert S. Bresalier University of Texas M. D. Anderson Cancer Center, Houston, USA
    Steven H. Itzkowitz Mount Sinai Medical Center, NY, USA
  • 3. Editorial Office
  • 4. Articles
  • 5. Instructions for Authors
  • 6. File Download (PDF version)
  • 7. Ethical Standards
  • 8. Peer Review

    All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
    The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.

    The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.

Search

Search

Year

to

Article Type

Original Article

Split Viewer

Patients’ Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in Korea

Young-Hak Cho1, Dae Ho Kim1, Jae Myung Cha1,2, Yoon Tae Jeen3, Jeong Seop Moon4, Jin-Oh Kim5, Sang Kil Lee6, Yu Kyung Cho7, Jong Pil Im8, Jae Young Jang2, Jeong Eun Shin9, Soon Man Yoon10, Yunho Jung5, Eun Sun Kim3, Kang Nyeong Lee11, Soo-Jeong Cho12, Yeol Kim13, Bo Young Park13

1Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea, 2Department of Medicine, Kyung Hee University College of Medicine, Seoul, Korea, 3Department of Medicine, Korea University College of Medicine, Seoul, Korea, 4Department of Medicine, Inje University College of Medicine, Seoul, Korea, 5Department of Medicine, Soonchunhyang University College of Medicine, Seoul, Korea, 6Department of Medicine, Yonsei University College of Medicine, Seoul, Korea, 7Department of Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea, 8Department of Medicine, Seoul National University Hospital, Seoul, Korea, 9Department of Medicine, Dankook University College of Medicine, Cheonan, Korea, 10Department of Medicine, Chungbuk National University College of Medicine, Cheongju, Korea, 11Department of Medicine, Hanyang University College of Medicine, Seoul, Korea, 12Center for Gastric Cancer, Goyang, Korea, 13Cancer Early Detection Branch, National Cancer Center, Goyang, Korea

Correspondence to: Jae Myung Cha, Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 05278, Korea, Tel: +82-2-440-6113, Fax: +82-2-440-6295, E-mail: drcha@khu.ac.kr

Received: January 9, 2017; Revised: February 24, 2017; Accepted: February 24, 2017

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Gut Liver 2017;11(6):821-827. https://doi.org/10.5009/gnl17025

Published online July 28, 2017, Published date November 15, 2017

Copyright © Gut and Liver.

Background/Aims

The adoption of colonoscopy as a primary colorectal cancer (CRC) screening technique has been argued for in Korea, without evidence of patient preferences. This study aimed to investigate patients’ preferences for the primary CRC screening test for the National Cancer Screening Program (NCSP).

Methods

Between June and August 2016, 414 individuals aged ≥50 years who participated in the NCSP were prospectively invited to complete a questionnaire regarding their preferences for the primary CRC screening test and the reasons for their selection.

Results

Among the 396 respondents who completed the questionnaire, 124 individuals (31.3%) preferred the fecal immunochemical test (FIT), whereas 272 individuals (68.7%) preferred colonoscopy. Elderly participants preferred the FIT (p<0.001), whereas participants with a higher education level (p=0.030), a higher income level (p=0.009), or individuals with a family member (p=0.028) or acquaintance (p=0.013) with a history of CRC preferred colonoscopy. Only 12.9% of participants had a bad experience with a previous FIT; however, 39.3% of participants had a bad experience with a previous colonoscopy.

Conclusions

Colonoscopy was preferred to FIT in a 2.2:1 ratio as the primary CRC screening test for the NCSP. Patients’ preference for colonoscopy should be considered for the NCSP in Korea.

Keywords: Colorectal neoplasms, Fecal occult blood test, Colonoscopy, Screening, Preference

The incidence of colorectal cancer (CRC) has increased rapidly in Western and Asian countries.1 Many countries have started CRC screening programs; however, screening modalities and strategies differ among countries.24 In Korea, the National Cancer Screening Program (NCSP) provides a single annual fecal immunochemical test (FIT) for adults aged ≥50 years, and secondary confirmatory colonoscopy for those with positive FIT results.5,6 The efficacy of a FIT-based screening program may ultimately depend on FIT and colonoscopy participation rates. However, the CRC screening rate in Korea7 has remained lower than those for other cancers, similar to other countries.8,9 Several Western countries such as Australia, Germany, Poland, Switzerland, and the United States use colonoscopy as a primary CRC screening test.7 Therefore, the adoption of colonoscopy as a primary CRC screening method has been argued in Korea, but without evidence of patient preferences.

Information about CRC screening preferences will be used to plan a primary colonoscopy screening strategy as well as to identify deficits in the current colonoscopic resources in the NCSP. However, some studies have reported variations in patient preferences for FIT1014 and colonoscopy1218 as a primary CRC screening test. Information about CRC screening preference is essential for checking the availability of national resources to deliver a primary screening program. Until now, however, no data have been available about patient CRC screening method preferences under the NCSP in Korea. Here we conducted a survey to assess patient preferences about CRC screening methods in the NCSP.

1. Patients

Between June and August 2016, 1,093 asymptomatic subjects aged ≥50 years, who participated in the NCSP, were invited to complete a questionnaire. The survey items were designed to investigate the patient’s preferences regarding FIT versus colonoscopy as a primary CRC screening method. The questionnaire included questions about sex, age, education, marital status, religion, occupation, income level, drinking, smoking, comorbid disease, history of colectomy, family history of CRC in ≥ first-degree relatives at any age, knowledge of CRC warning symptoms, previous participation in the NCSP, previous experience with FIT or colonoscopy, and preference as well as reason for the preference of FIT or colonoscopy as the primary CRC screening test. Comorbid disease included hypertension, type II diabetes mellitus, cardiovascular disease, chronic renal disease, cerebrovascular disease or any malignancy. Respondents who did not complete the questionnaire were excluded from the analysis. All responses were anonymous, and all respondents voluntary participated. This study was approved by the Institutional Review Board of Kyung Hee University Hospital at Gang-dong (KHNMC IRB number: 2016-05-027).

2. Questionnaires for preference

The questionnaire regarding primary CRC screening test preference was designed to elicit the patient’s preference for the primary CRC screening method and the reasons therein. Patients were asked which screening strategy they would prefer, if given a choice in the future (Supplementary Material 1). The questionnaire asked patients about (1) experience with and opinions about the NCSP; and (2) preference and reason for the preference of a particular primary CRC screening test. The questionnaire was based on a literature review1921 and semi-structured discussions with the “Committee of Endoscopy Quality Improvement in the Korean Society of Gastrointestinal Endoscopy.” To help participants choose an appropriate primary CRC screening test, an information sheet was provided to participants with reliable, accurate, and unbiased information about the advantages and disadvantages of FIT versus colonoscopy to enable patients to answer the study questionnaire as accurately and reliably as possible. The questionnaire was confirmed as reliable and valid by four gastroenterology fellows who were not involved in this study, and answers from this group were used to revise the survey questionnaire. Reported completion times were 10 to 15 minutes. The questions were dichotomous (yes/no) or multiple choice.

3. Statistical analysis

For the sample size estimation, we assumed that the 2-fold difference in the preference for CRC screening tools between colonoscopy and FIT would be sufficient for clinicians to recommend colonoscopy rather than FIT as a primary screening test. Based on these assumptions and 26.6% FIT participation rate of NCSP, 2014 in Korea, a minimum of 51 subjects were required for a power of 80% to detect a difference at p<0.05 level of significance.

Categorical variables are expressed as numbers (percentage), whereas continuous variables are expressed as mean±standard deviation. Factors influencing preference for CRC screening tests were evaluated using binary logistic regression with odds ratios and a 95% confidence interval. Two-tailed p-values <0.05 were considered statistically significant. Statistical analyses were performed using the SPSS version 18.0 for Windows (SPSS Inc., Chicago, IL, USA).

Among 1,093 asymptomatic subjects aged ≥50 years who participated in the NCSP in our hospital, 414 answered this survey for a response rate of 37.9%. Overall, the survey results from 396 respondents were analyzed after the exclusion of 16 surveys because of incomplete answers (n=4), duplicate answers (n=2), participant age <50 (n=4), or no preferred primary screening (n=8). The complete overall response rate was 36.2%.

1. Characteristics of the survey respondents

The respondents included 139 men (35.1%) and 257 women (64.9%) with a mean age of 64.1±7.6 years. Table 1 shows the demographic characteristics and baseline clinical information of the respondents by CRC screening method preference: FIT preference group versus colonoscopy preference group. In this study, colonoscopy was preferred to FIT at a ratio of 2.2 to 1 (68.7% vs 31.3%) as a primary CRC screening test in the NCSP. There was no intergroup difference in age or sex distribution. However, alcohol drinkers as well as participants with a higher education or income level, a previous colectomy history, a family history of CRC, or acquaintances with CRC preferred colonoscopy.

2. Factors influencing screening method preference and reasons

Elderly participants significantly preferred the FIT (p<0.001) with an age-dependent correlation (Table 2). However, sex did not influence preference. In contrast, participants who were alcohol drinkers (p=0.024), had a higher education (p=0.030) or income level (p=0.025), had a family history of CRC (p=0.028), or had acquaintances with CRC (p=0.013) preferred colonoscopy. For the patients’ preferences in Table 3, FIT was preferred for its convenience and simplicity (72.8%) as well as low cost (4.8%). In contrast, colonoscopy was preferred for its accuracy (79.4%) and ability to provide therapeutic options (15.8%).

3. Experience with and opinions about the NCSP

More than 90% of participants frequently participated in the NCSP (Table 4). Only 12.9% of participants had a bad experience with FIT, the major reasons for which were stool sampling (77.8%), and storage and transportation (20.0%). Conversely, 39.3% of participants had a bad experience with colonoscopy, primarily due to bowel preparation (68.9%) and the complicated examination process itself (25.5%).

Primary colonoscopy screening may be superior considering its ability to remove the adenomatous polyp,22 although FIT is a more efficient CRC screening method.4,23 Choices for CRC screening options differ among countries.24 Although some Western countries provide primary colonoscopy screening,7 its adoption should be based on patient preference about screening methods, socioeconomic considerations, the current capacity to perform colonoscopy in each country, and its efficacy at preventing CRC. The planning of a primary colonoscopy screening strategy in Korea should be based on NCSP participant preference data. Our results indicate that colonoscopy was preferred to FIT at a ratio of 2.2 to 1 (68.7% vs 31.3%) as a primary CRC screening test by NCSP participants. Our study showed that elderly participants preferred FIT, whereas participants with higher education and income levels as well as those with family members or acquaintances with CRC preferred colonoscopy. The current study is the first to evaluate primary CRC screening method preferences in NCSP participants.

Four large randomized controlled trials are currently evaluating the completion rate of a primary colonoscopy screening program,2427 and the long-term results are expected in the next decade. In a randomized controlled trial comparing primary colonoscopy with biannual FIT in Spain, the participation rate was higher in FIT group than in colonoscopy group (34.2% vs 24.6%, p<0.001).24 The different participation rates resulted in the same CRC detection rate in both groups. In a recent German population–based case-control study,28 only 1.7% of the patients with CRC underwent screening colonoscopy versus 12% of the patients without CRC. In a meta-analysis of prospective CRC screening studies,29 the overall participation rates for FIT and colonoscopy were 42% and 28%, respectively. In the United States, participation rates were higher for FIT group than colonoscopy group (58.8% vs 42.4%, respectively, p<0.001).23 Our study result contrasted those of previous studies23,24,29,30 in that colonoscopy was preferred to FIT; however, our findings may be cautiously interpreted as socioeconomic status, the capacity to perform colonoscopy, and perceived awareness of CRC may differ among countries. In Korea, the excellent accessibility and low cost of colonoscopy, and the availability of experienced colonoscopists may have influenced our results of a higher preference for colonoscopy. However, sufficient information should be provided to participants about the advantages and disadvantages of FIT versus colonoscopy to enable their informed decisions, as their choice may change after education. For example, in a CRC screening from Hong Kong,19 patients initially chose colonoscopy over FIT (47.4% vs 21.8%, respectively); however, 27.1% of participants changed to FIT from colonoscopy and 8% changed to colonoscopy from FIT after the educational session. As a result, the final participation rate was higher in the FIT group than in the colonoscopy group (61% vs 39%, respectively).

Considering the lower participation rate of CRC screening than those for other cancers,79 strategies to increase participation rates are needed. Accordingly, the choice of screening modality may encourage individuals to participate, as we noted substantial variation in CRC screening method preference by age, family history of CRC, and socioeconomic status. Furthermore, a detailed information system, such as interviews, an online system, or leaflets should be provided to increase the participation rate through their informed decisions. Considering that only 12.9% of participants reported a previous bad experience with FIT and 39.3% experienced a bad experience with colonoscopy, sufficient information about the advantages and disadvantages of FIT and colonoscopy may be essential to increasing CRC screening participation rates. In a multi-criteria decision analysis, inconvenience, safety, and testing frequency were most significantly associated with intention to attend.30

This study had some limitations. First is the possibility of selection bias derived from its single-center design. In addition, there is likely some sampling bias in the participants since the complete overall response rate was only 36.2% and that all respondents are thought to be interested in the NCSP. Second, our study was based on a questionnaire rather than actual data from administrative or clinical trials. As demonstrated in a CRC screening program of Hong Kong,19 a significant number of participants may change their initial opinion just before the actual CRC screening tests are performed. Therefore, an actual clinical trial on this issue is warranted in the future. However, this kind of study may incur large economic and resource burdens. Third, this survey tool was not verified for the reliability and validity. However, members of “Committee of Endoscopy Quality Improvement in the Korean Society of Gastrointestinal Endoscopy” checked this survey tool as we failed to find any verified survey tools on this issue. Finally, previous history of colon polyp was not investigated in this study. As patients with experience of polypectomy may be more aware of importance of colon polyp removal, it would be better if they were excluded from this study.

In conclusion, colonoscopy was preferred to FIT at a ratio of 2.2 to 1 in NCSP participants in Korea. The demonstrated colonoscopy preference should be considered in the creation of a primary colonoscopy screening strategy in Korea. However, actual clinical trial data about this issue are needed.

This study was supported by a National Cancer Center grant (1660740-1).

Author contributions: Y.H.C., D.H.K., and J.M.C. contributed to the conception and design of the study and were responsible for the acquisition, analysis, and interpretation of data. Y.T.J., J.S.M., J.O.K., S.K.L., and Y.K.C. were responsible for the analysis and interpretation of data as well as writing a manuscript. J.P.I., J.Y.J., J.E.S., S.M.Y., Y.J., E.S.K., K.N.L., and S.J.C. revised the manuscript. Y.K. and B.Y.P. rechecked final manuscript and English revision. All authors read and approved the final manuscript.

Respondents’ Demographic Characteristics and Baseline Clinical Information According to the Preferred CRC Screening Method Preference

Clinical dataPreference for FIT (n=124)Preference for colonoscopy (n=272)p-value
Age, yr66.17±8.0963.17±7.250.208
Male sex39 (31.5)100 (36.8)0.304
Past/current smoker14 (11.4)42 (15.5)0.278
Alcohol drinking19 (15.4)70 (25.8)0.022
Education (university or above)29 (23.8)91 (34.9)0.029
Marital status (married)113 (91.1)252 (93.3)0.436
Religion (yes)84 (67.7)175 (64.3)0.509
Employment0.139
 Full-/part-time33 (26.6)92 (34.1)
 Not working/homemaker91 (73.4)178 (65.9)
Income (dollars/mo)0.013
 <1,81875 (65.2)141 (54.2)
 1,818–4,54537 (32.2)90 (34.6)
 >4,5453 (2.6)29 (11.2)
Comorbid disease (yes)63 (50.8)126 (46.3)0.408
Previous colectomy (yes)2 (1.6)17 (6.3)0.043
Family history of CRC6 (4.8)33 (12.2)0.023
Acquaintances with CRC (yes)18 (14.6)71 (26.1)0.012

Factors Influencing Patients’ Preference for a CRC Screening Method

VariableOR (95% CI)

FIT preferenceColonoscopy preferencep-value
Age group, yr0.001
 50–59ReferenceReference
 60–691.582 (0.926–2.703)0.632 (0.370–1.080)0.094
 ≥703.037 (1.671–5.519)0.329 (0.181–0.598)<0.001
Sex
 MaleReferenceReference
 Female1.267 (0.806–1.992)0.789 (0.502–1.240)0.305
Smoker
 NoReferenceReference
 Yes0.700 (0.367–1.337)1.428 (0.748–2.726)0.280
Alcohol drinking
 NoReferenceReference
 Yes0.525 (0.300–0.918)1.906 (1.089–3.336)0.024
Education
 High school or lessReferenceReference
 University or more0.583 (0.357–0.949)1.717 (1.053–2.798)0.030
Marital status
 MarriedReferenceReference
 Unmarried0.734 (0.336–1.604)1.363 (0.623–2.980)0.438
Religion
 NoReferenceReference
 Yes1.164 (0.742–1.827)0.859 (0.547–1.349)0.509
Full-/part-time employment
 NoReferenceReference
 Yes1.425 (0.890–2.283)0.702 (0.438–1.124)0.140
Income (dollars/mo)0.025
 <1,818ReferenceReference
 1,818–4,5450.773 (0.481–1.242)1.294 (0.805–2.079)0.287
 >4,5450.194 (0.057–0.660)5.142 (1.516–17.438)0.009
Comorbid disease
 NoReferenceReference
 Yes1.197 (0.782–1.831)0.836 (0.546–1.278)0.408
Previous colectomy
 NoReferenceReference
 Yes0.243 (0.055–1.069)4.115 (0.936–18.096)0.061
Family history of CRC
 NoReferenceReference
 Yes0.367 (0.149–0.900)2.727 (1.112–6.690)0.028
Acquaintances with CRC
 NoReferenceReference
 Yes0.485 (0.275–0.857)2.061 (1.167–3.638)0.013

Reasons Why Patients Prefer the FIT versus Colonoscopy

Reason for choosingPercent
FIT
 FIT is convenient and simple72.8
 FIT is safe2.4
 FIT is inexpensive4.8
 Colonoscopy is too complicated a process12.8
 Other7.2
Colonoscopy
 Colonoscopy is accurate79.4
 Colonoscopy can provide therapeutic options15.8
 FIT is inconvenient1.5
 Colonoscopy is convenient1.5
 Other1.8

Respondents’ Experiences with and Opinions about the NCSP

OpinionNo. (%)
Experience of NCSP participationAnnually–frequently357 (90.2)
Often–infrequently39 (9.8)
Experience of FIT participation
 Experience of FIT participationNone56 (14.1)
 Bad experience from FITYes44 (12.9)
 Cause of bad experience from FITStool sampling35 (77.8)
Stool storage and transportation9 (20.0)
Other1 (2.2)
Experience of colonoscopy participation
 Experience of colonoscopy participationNone134 (33.8)
 Bad experience with colonoscopyYes103 (39.3)
 Cause of bad experience from colonoscopyComplicated preparation process73 (68.9)
Complicated colonoscopy process itself27 (25.5)
High medical cost3 (2.8)
Other3 (2.8)

  1. Lin, OS, Kozarek, RA, and Cha, JM (2014). Impact of sigmoidoscopy and colonoscopy on colorectal cancer incidence and mortality: an evidence-based review of published prospective and retrospective studies. Intest Res. 12, 268-274.
    Pubmed KoreaMed CrossRef
  2. Schreuders, EH, Ruco, A, and Rabeneck, L (2015). Colorectal cancer screening: a global overview of existing programmes. Gut. 64, 1637-1649.
    Pubmed CrossRef
  3. van der Steen, A, Knudsen, AB, and van Hees, F (2015). Optimal colorectal cancer screening in states’ low-income, uninsured populations: the case of South Carolina. Health Serv Res. 50, 768-789.
    CrossRef
  4. Gupta, S, Halm, EA, and Rockey, DC (2013). Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 173, 1725-1732.
    Pubmed KoreaMed
  5. Shin, A, Choi, KS, and Jun, JK (2013). Validity of fecal occult blood test in the national cancer screening program, Korea. PLoS One. 8, e79292.
    Pubmed KoreaMed CrossRef
  6. Yoo, KY (2008). Cancer control activities in the Republic of Korea. Jpn J Clin Oncol. 38, 327-333.
    Pubmed CrossRef
  7. Vleugels, JL, van Lanschot, MC, and Dekker, E (2016). Colorectal cancer screening by colonoscopy: putting it into perspective. Dig Endosc. 28, 250-259.
    CrossRef
  8. Klabunde, CN, Lanier, D, Meissner, HI, Breslau, ES, and Brown, ML (2008). Improving colorectal cancer screening through research in primary care settings. Med Care. 46, S1-S4.
    Pubmed CrossRef
  9. Meissner, HI, Breen, N, Klabunde, CN, and Vernon, SW (2006). Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 15, 389-394.
    Pubmed CrossRef
  10. Almog, R, Ezra, G, Lavi, I, Rennert, G, and Hagoel, L (2008). The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev. 17, 430-437.
    Pubmed CrossRef
  11. Janz, NK, Lakhani, I, Vijan, S, Hawley, ST, Chung, LK, and Katz, SJ (2007). Determinants of colorectal cancer screening use, attempts, and non-use. Prev Med. 44, 452-458.
    Pubmed CrossRef
  12. Ling, BS, Moskowitz, MA, Wachs, D, Pearson, B, and Schroy, PC (2001). Attitudes toward colorectal cancer screening tests. J Gen Intern Med. 16, 822-830.
    CrossRef
  13. Schroy, PC, Lal, S, Glick, JT, Robinson, PA, Zamor, P, and Heeren, TC (2007). Patient preferences for colorectal cancer screening: how does stool DNA testing fare?. Am J Manag Care. 13, 393-400.
    Pubmed
  14. Schroy, PC, Emmons, K, and Peters, E (2011). The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial. Med Decis Making. 31, 93-107.
    CrossRef
  15. Hawley, ST, Volk, RJ, Krishnamurthy, P, Jibaja-Weiss, M, Vernon, SW, and Kneuper, S (2008). Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 46, S10-S16.
    Pubmed CrossRef
  16. DeBourcy, AC, Lichtenberger, S, Felton, S, Butterfield, KT, Ahnen, DJ, and Denberg, TD (2008). Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 23, 169-174.
    CrossRef
  17. Wolf, RL, Basch, CE, Brouse, CH, Shmukler, C, and Shea, S (2006). Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health. 96, 809-811.
    Pubmed KoreaMed CrossRef
  18. Pignone, M, Bucholtz, D, and Harris, R (1999). Patient preferences for colon cancer screening. J Gen Intern Med. 14, 432-437.
    Pubmed KoreaMed CrossRef
  19. Wong, MC, John, GK, and Hirai, HW (2012). Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys. Cancer Causes Control. 23, 1541-1548.
    Pubmed CrossRef
  20. Naing, C, Jun, YK, and Yee, WM (2014). Willingness to take a screening test for colorectal cancer: a community-based survey in Malaysia. Eur J Cancer Prev. 23, 71-75.
    CrossRef
  21. Saengow, U, Chongsuwiwatvong, V, Geater, A, and Birch, S (2015). Preferences and acceptance of colorectal cancer screening in Thailand. Asian Pac J Cancer Prev. 16, 2269-2276.
    Pubmed CrossRef
  22. Wong, MC, Ching, JY, Chan, VC, and Sung, JJ (2015). The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy. Sci Rep. 5, 13568.
    Pubmed KoreaMed CrossRef
  23. Singal, AG, Gupta, S, and Tiro, JA (2016). Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: a randomized controlled trial in a safety-net health system. Cancer. 122, 456-463.
    CrossRef
  24. Quintero, E, Castells, A, and Bujanda, L (2012). Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 366, 697-706.
    Pubmed CrossRef
  25. ClinicalTrials.gov (c2016). CONFIRM trial [Internet].[cited 2016 Dec 19].
    Available from: http://www.clinicaltrials.gov/ct2/show/NCT01239082
  26. Kaminski, MF, Bretthauer, M, and Zauber, AG (2012). The NordICC study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy. 44, 695-702.
    Pubmed KoreaMed CrossRef
  27. ClinicalTrials.gov (c2016). SCREESCO trial [Internet].[cited 2016 Dec 19].
    Available from: http://www.clinicaltrials.gov/ct2/show/NCT02078804
  28. Brenner, H, Chang-Claude, J, Jansen, L, Knebel, P, Stock, C, and Hoffmeister, M (2014). Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology. 146, 709-717.
    CrossRef
  29. Khalid-de Bakker, C, Jonkers, D, Smits, K, Mesters, I, Masclee, A, and Stockbrügger, R (2011). Participation in colorectal cancer screening trials after first-time invitation: a systematic review. Endoscopy. 43, 1059-1086.
    Pubmed CrossRef
  30. Hummel, JM, Steuten, LG, Groothuis-Oudshoorn, CJ, Mulder, N, and Ijzerman, MJ (2013). Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis. Appl Health Econ Health Policy. 11, 499-507.
    Pubmed CrossRef

Article

Original Article

Gut and Liver 2017; 11(6): 821-827

Published online November 15, 2017 https://doi.org/10.5009/gnl17025

Copyright © Gut and Liver.

Patients’ Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in Korea

Young-Hak Cho1, Dae Ho Kim1, Jae Myung Cha1,2, Yoon Tae Jeen3, Jeong Seop Moon4, Jin-Oh Kim5, Sang Kil Lee6, Yu Kyung Cho7, Jong Pil Im8, Jae Young Jang2, Jeong Eun Shin9, Soon Man Yoon10, Yunho Jung5, Eun Sun Kim3, Kang Nyeong Lee11, Soo-Jeong Cho12, Yeol Kim13, Bo Young Park13

1Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Korea, 2Department of Medicine, Kyung Hee University College of Medicine, Seoul, Korea, 3Department of Medicine, Korea University College of Medicine, Seoul, Korea, 4Department of Medicine, Inje University College of Medicine, Seoul, Korea, 5Department of Medicine, Soonchunhyang University College of Medicine, Seoul, Korea, 6Department of Medicine, Yonsei University College of Medicine, Seoul, Korea, 7Department of Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea, 8Department of Medicine, Seoul National University Hospital, Seoul, Korea, 9Department of Medicine, Dankook University College of Medicine, Cheonan, Korea, 10Department of Medicine, Chungbuk National University College of Medicine, Cheongju, Korea, 11Department of Medicine, Hanyang University College of Medicine, Seoul, Korea, 12Center for Gastric Cancer, Goyang, Korea, 13Cancer Early Detection Branch, National Cancer Center, Goyang, Korea

Correspondence to: Jae Myung Cha, Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 05278, Korea, Tel: +82-2-440-6113, Fax: +82-2-440-6295, E-mail: drcha@khu.ac.kr

Received: January 9, 2017; Revised: February 24, 2017; Accepted: February 24, 2017

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background/Aims

The adoption of colonoscopy as a primary colorectal cancer (CRC) screening technique has been argued for in Korea, without evidence of patient preferences. This study aimed to investigate patients’ preferences for the primary CRC screening test for the National Cancer Screening Program (NCSP).

Methods

Between June and August 2016, 414 individuals aged ≥50 years who participated in the NCSP were prospectively invited to complete a questionnaire regarding their preferences for the primary CRC screening test and the reasons for their selection.

Results

Among the 396 respondents who completed the questionnaire, 124 individuals (31.3%) preferred the fecal immunochemical test (FIT), whereas 272 individuals (68.7%) preferred colonoscopy. Elderly participants preferred the FIT (p<0.001), whereas participants with a higher education level (p=0.030), a higher income level (p=0.009), or individuals with a family member (p=0.028) or acquaintance (p=0.013) with a history of CRC preferred colonoscopy. Only 12.9% of participants had a bad experience with a previous FIT; however, 39.3% of participants had a bad experience with a previous colonoscopy.

Conclusions

Colonoscopy was preferred to FIT in a 2.2:1 ratio as the primary CRC screening test for the NCSP. Patients’ preference for colonoscopy should be considered for the NCSP in Korea.

Keywords: Colorectal neoplasms, Fecal occult blood test, Colonoscopy, Screening, Preference

INTRODUCTION

The incidence of colorectal cancer (CRC) has increased rapidly in Western and Asian countries.1 Many countries have started CRC screening programs; however, screening modalities and strategies differ among countries.24 In Korea, the National Cancer Screening Program (NCSP) provides a single annual fecal immunochemical test (FIT) for adults aged ≥50 years, and secondary confirmatory colonoscopy for those with positive FIT results.5,6 The efficacy of a FIT-based screening program may ultimately depend on FIT and colonoscopy participation rates. However, the CRC screening rate in Korea7 has remained lower than those for other cancers, similar to other countries.8,9 Several Western countries such as Australia, Germany, Poland, Switzerland, and the United States use colonoscopy as a primary CRC screening test.7 Therefore, the adoption of colonoscopy as a primary CRC screening method has been argued in Korea, but without evidence of patient preferences.

Information about CRC screening preferences will be used to plan a primary colonoscopy screening strategy as well as to identify deficits in the current colonoscopic resources in the NCSP. However, some studies have reported variations in patient preferences for FIT1014 and colonoscopy1218 as a primary CRC screening test. Information about CRC screening preference is essential for checking the availability of national resources to deliver a primary screening program. Until now, however, no data have been available about patient CRC screening method preferences under the NCSP in Korea. Here we conducted a survey to assess patient preferences about CRC screening methods in the NCSP.

MATERIALS AND METHODS

1. Patients

Between June and August 2016, 1,093 asymptomatic subjects aged ≥50 years, who participated in the NCSP, were invited to complete a questionnaire. The survey items were designed to investigate the patient’s preferences regarding FIT versus colonoscopy as a primary CRC screening method. The questionnaire included questions about sex, age, education, marital status, religion, occupation, income level, drinking, smoking, comorbid disease, history of colectomy, family history of CRC in ≥ first-degree relatives at any age, knowledge of CRC warning symptoms, previous participation in the NCSP, previous experience with FIT or colonoscopy, and preference as well as reason for the preference of FIT or colonoscopy as the primary CRC screening test. Comorbid disease included hypertension, type II diabetes mellitus, cardiovascular disease, chronic renal disease, cerebrovascular disease or any malignancy. Respondents who did not complete the questionnaire were excluded from the analysis. All responses were anonymous, and all respondents voluntary participated. This study was approved by the Institutional Review Board of Kyung Hee University Hospital at Gang-dong (KHNMC IRB number: 2016-05-027).

2. Questionnaires for preference

The questionnaire regarding primary CRC screening test preference was designed to elicit the patient’s preference for the primary CRC screening method and the reasons therein. Patients were asked which screening strategy they would prefer, if given a choice in the future (Supplementary Material 1). The questionnaire asked patients about (1) experience with and opinions about the NCSP; and (2) preference and reason for the preference of a particular primary CRC screening test. The questionnaire was based on a literature review1921 and semi-structured discussions with the “Committee of Endoscopy Quality Improvement in the Korean Society of Gastrointestinal Endoscopy.” To help participants choose an appropriate primary CRC screening test, an information sheet was provided to participants with reliable, accurate, and unbiased information about the advantages and disadvantages of FIT versus colonoscopy to enable patients to answer the study questionnaire as accurately and reliably as possible. The questionnaire was confirmed as reliable and valid by four gastroenterology fellows who were not involved in this study, and answers from this group were used to revise the survey questionnaire. Reported completion times were 10 to 15 minutes. The questions were dichotomous (yes/no) or multiple choice.

3. Statistical analysis

For the sample size estimation, we assumed that the 2-fold difference in the preference for CRC screening tools between colonoscopy and FIT would be sufficient for clinicians to recommend colonoscopy rather than FIT as a primary screening test. Based on these assumptions and 26.6% FIT participation rate of NCSP, 2014 in Korea, a minimum of 51 subjects were required for a power of 80% to detect a difference at p<0.05 level of significance.

Categorical variables are expressed as numbers (percentage), whereas continuous variables are expressed as mean±standard deviation. Factors influencing preference for CRC screening tests were evaluated using binary logistic regression with odds ratios and a 95% confidence interval. Two-tailed p-values <0.05 were considered statistically significant. Statistical analyses were performed using the SPSS version 18.0 for Windows (SPSS Inc., Chicago, IL, USA).

RESULTS

Among 1,093 asymptomatic subjects aged ≥50 years who participated in the NCSP in our hospital, 414 answered this survey for a response rate of 37.9%. Overall, the survey results from 396 respondents were analyzed after the exclusion of 16 surveys because of incomplete answers (n=4), duplicate answers (n=2), participant age <50 (n=4), or no preferred primary screening (n=8). The complete overall response rate was 36.2%.

1. Characteristics of the survey respondents

The respondents included 139 men (35.1%) and 257 women (64.9%) with a mean age of 64.1±7.6 years. Table 1 shows the demographic characteristics and baseline clinical information of the respondents by CRC screening method preference: FIT preference group versus colonoscopy preference group. In this study, colonoscopy was preferred to FIT at a ratio of 2.2 to 1 (68.7% vs 31.3%) as a primary CRC screening test in the NCSP. There was no intergroup difference in age or sex distribution. However, alcohol drinkers as well as participants with a higher education or income level, a previous colectomy history, a family history of CRC, or acquaintances with CRC preferred colonoscopy.

2. Factors influencing screening method preference and reasons

Elderly participants significantly preferred the FIT (p<0.001) with an age-dependent correlation (Table 2). However, sex did not influence preference. In contrast, participants who were alcohol drinkers (p=0.024), had a higher education (p=0.030) or income level (p=0.025), had a family history of CRC (p=0.028), or had acquaintances with CRC (p=0.013) preferred colonoscopy. For the patients’ preferences in Table 3, FIT was preferred for its convenience and simplicity (72.8%) as well as low cost (4.8%). In contrast, colonoscopy was preferred for its accuracy (79.4%) and ability to provide therapeutic options (15.8%).

3. Experience with and opinions about the NCSP

More than 90% of participants frequently participated in the NCSP (Table 4). Only 12.9% of participants had a bad experience with FIT, the major reasons for which were stool sampling (77.8%), and storage and transportation (20.0%). Conversely, 39.3% of participants had a bad experience with colonoscopy, primarily due to bowel preparation (68.9%) and the complicated examination process itself (25.5%).

DISCUSSION

Primary colonoscopy screening may be superior considering its ability to remove the adenomatous polyp,22 although FIT is a more efficient CRC screening method.4,23 Choices for CRC screening options differ among countries.24 Although some Western countries provide primary colonoscopy screening,7 its adoption should be based on patient preference about screening methods, socioeconomic considerations, the current capacity to perform colonoscopy in each country, and its efficacy at preventing CRC. The planning of a primary colonoscopy screening strategy in Korea should be based on NCSP participant preference data. Our results indicate that colonoscopy was preferred to FIT at a ratio of 2.2 to 1 (68.7% vs 31.3%) as a primary CRC screening test by NCSP participants. Our study showed that elderly participants preferred FIT, whereas participants with higher education and income levels as well as those with family members or acquaintances with CRC preferred colonoscopy. The current study is the first to evaluate primary CRC screening method preferences in NCSP participants.

Four large randomized controlled trials are currently evaluating the completion rate of a primary colonoscopy screening program,2427 and the long-term results are expected in the next decade. In a randomized controlled trial comparing primary colonoscopy with biannual FIT in Spain, the participation rate was higher in FIT group than in colonoscopy group (34.2% vs 24.6%, p<0.001).24 The different participation rates resulted in the same CRC detection rate in both groups. In a recent German population–based case-control study,28 only 1.7% of the patients with CRC underwent screening colonoscopy versus 12% of the patients without CRC. In a meta-analysis of prospective CRC screening studies,29 the overall participation rates for FIT and colonoscopy were 42% and 28%, respectively. In the United States, participation rates were higher for FIT group than colonoscopy group (58.8% vs 42.4%, respectively, p<0.001).23 Our study result contrasted those of previous studies23,24,29,30 in that colonoscopy was preferred to FIT; however, our findings may be cautiously interpreted as socioeconomic status, the capacity to perform colonoscopy, and perceived awareness of CRC may differ among countries. In Korea, the excellent accessibility and low cost of colonoscopy, and the availability of experienced colonoscopists may have influenced our results of a higher preference for colonoscopy. However, sufficient information should be provided to participants about the advantages and disadvantages of FIT versus colonoscopy to enable their informed decisions, as their choice may change after education. For example, in a CRC screening from Hong Kong,19 patients initially chose colonoscopy over FIT (47.4% vs 21.8%, respectively); however, 27.1% of participants changed to FIT from colonoscopy and 8% changed to colonoscopy from FIT after the educational session. As a result, the final participation rate was higher in the FIT group than in the colonoscopy group (61% vs 39%, respectively).

Considering the lower participation rate of CRC screening than those for other cancers,79 strategies to increase participation rates are needed. Accordingly, the choice of screening modality may encourage individuals to participate, as we noted substantial variation in CRC screening method preference by age, family history of CRC, and socioeconomic status. Furthermore, a detailed information system, such as interviews, an online system, or leaflets should be provided to increase the participation rate through their informed decisions. Considering that only 12.9% of participants reported a previous bad experience with FIT and 39.3% experienced a bad experience with colonoscopy, sufficient information about the advantages and disadvantages of FIT and colonoscopy may be essential to increasing CRC screening participation rates. In a multi-criteria decision analysis, inconvenience, safety, and testing frequency were most significantly associated with intention to attend.30

This study had some limitations. First is the possibility of selection bias derived from its single-center design. In addition, there is likely some sampling bias in the participants since the complete overall response rate was only 36.2% and that all respondents are thought to be interested in the NCSP. Second, our study was based on a questionnaire rather than actual data from administrative or clinical trials. As demonstrated in a CRC screening program of Hong Kong,19 a significant number of participants may change their initial opinion just before the actual CRC screening tests are performed. Therefore, an actual clinical trial on this issue is warranted in the future. However, this kind of study may incur large economic and resource burdens. Third, this survey tool was not verified for the reliability and validity. However, members of “Committee of Endoscopy Quality Improvement in the Korean Society of Gastrointestinal Endoscopy” checked this survey tool as we failed to find any verified survey tools on this issue. Finally, previous history of colon polyp was not investigated in this study. As patients with experience of polypectomy may be more aware of importance of colon polyp removal, it would be better if they were excluded from this study.

In conclusion, colonoscopy was preferred to FIT at a ratio of 2.2 to 1 in NCSP participants in Korea. The demonstrated colonoscopy preference should be considered in the creation of a primary colonoscopy screening strategy in Korea. However, actual clinical trial data about this issue are needed.

ACKNOWLEDGEMENTS

This study was supported by a National Cancer Center grant (1660740-1).

Author contributions: Y.H.C., D.H.K., and J.M.C. contributed to the conception and design of the study and were responsible for the acquisition, analysis, and interpretation of data. Y.T.J., J.S.M., J.O.K., S.K.L., and Y.K.C. were responsible for the analysis and interpretation of data as well as writing a manuscript. J.P.I., J.Y.J., J.E.S., S.M.Y., Y.J., E.S.K., K.N.L., and S.J.C. revised the manuscript. Y.K. and B.Y.P. rechecked final manuscript and English revision. All authors read and approved the final manuscript.

Supplementary Data

Table 1 Respondents’ Demographic Characteristics and Baseline Clinical Information According to the Preferred CRC Screening Method Preference

Clinical dataPreference for FIT (n=124)Preference for colonoscopy (n=272)p-value
Age, yr66.17±8.0963.17±7.250.208
Male sex39 (31.5)100 (36.8)0.304
Past/current smoker14 (11.4)42 (15.5)0.278
Alcohol drinking19 (15.4)70 (25.8)0.022
Education (university or above)29 (23.8)91 (34.9)0.029
Marital status (married)113 (91.1)252 (93.3)0.436
Religion (yes)84 (67.7)175 (64.3)0.509
Employment0.139
 Full-/part-time33 (26.6)92 (34.1)
 Not working/homemaker91 (73.4)178 (65.9)
Income (dollars/mo)0.013
 <1,81875 (65.2)141 (54.2)
 1,818–4,54537 (32.2)90 (34.6)
 >4,5453 (2.6)29 (11.2)
Comorbid disease (yes)63 (50.8)126 (46.3)0.408
Previous colectomy (yes)2 (1.6)17 (6.3)0.043
Family history of CRC6 (4.8)33 (12.2)0.023
Acquaintances with CRC (yes)18 (14.6)71 (26.1)0.012

Data are presented as mean±SD or number (%).

CRC, colorectal cancer; FIT, fecal immunochemical test.


Table 2 Factors Influencing Patients’ Preference for a CRC Screening Method

VariableOR (95% CI)

FIT preferenceColonoscopy preferencep-value
Age group, yr0.001
 50–59ReferenceReference
 60–691.582 (0.926–2.703)0.632 (0.370–1.080)0.094
 ≥703.037 (1.671–5.519)0.329 (0.181–0.598)<0.001
Sex
 MaleReferenceReference
 Female1.267 (0.806–1.992)0.789 (0.502–1.240)0.305
Smoker
 NoReferenceReference
 Yes0.700 (0.367–1.337)1.428 (0.748–2.726)0.280
Alcohol drinking
 NoReferenceReference
 Yes0.525 (0.300–0.918)1.906 (1.089–3.336)0.024
Education
 High school or lessReferenceReference
 University or more0.583 (0.357–0.949)1.717 (1.053–2.798)0.030
Marital status
 MarriedReferenceReference
 Unmarried0.734 (0.336–1.604)1.363 (0.623–2.980)0.438
Religion
 NoReferenceReference
 Yes1.164 (0.742–1.827)0.859 (0.547–1.349)0.509
Full-/part-time employment
 NoReferenceReference
 Yes1.425 (0.890–2.283)0.702 (0.438–1.124)0.140
Income (dollars/mo)0.025
 <1,818ReferenceReference
 1,818–4,5450.773 (0.481–1.242)1.294 (0.805–2.079)0.287
 >4,5450.194 (0.057–0.660)5.142 (1.516–17.438)0.009
Comorbid disease
 NoReferenceReference
 Yes1.197 (0.782–1.831)0.836 (0.546–1.278)0.408
Previous colectomy
 NoReferenceReference
 Yes0.243 (0.055–1.069)4.115 (0.936–18.096)0.061
Family history of CRC
 NoReferenceReference
 Yes0.367 (0.149–0.900)2.727 (1.112–6.690)0.028
Acquaintances with CRC
 NoReferenceReference
 Yes0.485 (0.275–0.857)2.061 (1.167–3.638)0.013

CRC, colorectal cancer; OR, odds ratio; CI, confidence interval; FIT, fecal immunochemical test.


Table 3 Reasons Why Patients Prefer the FIT versus Colonoscopy

Reason for choosingPercent
FIT
 FIT is convenient and simple72.8
 FIT is safe2.4
 FIT is inexpensive4.8
 Colonoscopy is too complicated a process12.8
 Other7.2
Colonoscopy
 Colonoscopy is accurate79.4
 Colonoscopy can provide therapeutic options15.8
 FIT is inconvenient1.5
 Colonoscopy is convenient1.5
 Other1.8

FIT, fecal immunochemical test.


Table 4 Respondents’ Experiences with and Opinions about the NCSP

OpinionNo. (%)
Experience of NCSP participationAnnually–frequently357 (90.2)
Often–infrequently39 (9.8)
Experience of FIT participation
 Experience of FIT participationNone56 (14.1)
 Bad experience from FITYes44 (12.9)
 Cause of bad experience from FITStool sampling35 (77.8)
Stool storage and transportation9 (20.0)
Other1 (2.2)
Experience of colonoscopy participation
 Experience of colonoscopy participationNone134 (33.8)
 Bad experience with colonoscopyYes103 (39.3)
 Cause of bad experience from colonoscopyComplicated preparation process73 (68.9)
Complicated colonoscopy process itself27 (25.5)
High medical cost3 (2.8)
Other3 (2.8)

NCSP, National Cancer Screening Program; FIT, fecal immunochemical test.


References

  1. Lin, OS, Kozarek, RA, and Cha, JM (2014). Impact of sigmoidoscopy and colonoscopy on colorectal cancer incidence and mortality: an evidence-based review of published prospective and retrospective studies. Intest Res. 12, 268-274.
    Pubmed KoreaMed CrossRef
  2. Schreuders, EH, Ruco, A, and Rabeneck, L (2015). Colorectal cancer screening: a global overview of existing programmes. Gut. 64, 1637-1649.
    Pubmed CrossRef
  3. van der Steen, A, Knudsen, AB, and van Hees, F (2015). Optimal colorectal cancer screening in states’ low-income, uninsured populations: the case of South Carolina. Health Serv Res. 50, 768-789.
    CrossRef
  4. Gupta, S, Halm, EA, and Rockey, DC (2013). Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med. 173, 1725-1732.
    Pubmed KoreaMed
  5. Shin, A, Choi, KS, and Jun, JK (2013). Validity of fecal occult blood test in the national cancer screening program, Korea. PLoS One. 8, e79292.
    Pubmed KoreaMed CrossRef
  6. Yoo, KY (2008). Cancer control activities in the Republic of Korea. Jpn J Clin Oncol. 38, 327-333.
    Pubmed CrossRef
  7. Vleugels, JL, van Lanschot, MC, and Dekker, E (2016). Colorectal cancer screening by colonoscopy: putting it into perspective. Dig Endosc. 28, 250-259.
    CrossRef
  8. Klabunde, CN, Lanier, D, Meissner, HI, Breslau, ES, and Brown, ML (2008). Improving colorectal cancer screening through research in primary care settings. Med Care. 46, S1-S4.
    Pubmed CrossRef
  9. Meissner, HI, Breen, N, Klabunde, CN, and Vernon, SW (2006). Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev. 15, 389-394.
    Pubmed CrossRef
  10. Almog, R, Ezra, G, Lavi, I, Rennert, G, and Hagoel, L (2008). The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev. 17, 430-437.
    Pubmed CrossRef
  11. Janz, NK, Lakhani, I, Vijan, S, Hawley, ST, Chung, LK, and Katz, SJ (2007). Determinants of colorectal cancer screening use, attempts, and non-use. Prev Med. 44, 452-458.
    Pubmed CrossRef
  12. Ling, BS, Moskowitz, MA, Wachs, D, Pearson, B, and Schroy, PC (2001). Attitudes toward colorectal cancer screening tests. J Gen Intern Med. 16, 822-830.
    CrossRef
  13. Schroy, PC, Lal, S, Glick, JT, Robinson, PA, Zamor, P, and Heeren, TC (2007). Patient preferences for colorectal cancer screening: how does stool DNA testing fare?. Am J Manag Care. 13, 393-400.
    Pubmed
  14. Schroy, PC, Emmons, K, and Peters, E (2011). The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial. Med Decis Making. 31, 93-107.
    CrossRef
  15. Hawley, ST, Volk, RJ, Krishnamurthy, P, Jibaja-Weiss, M, Vernon, SW, and Kneuper, S (2008). Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 46, S10-S16.
    Pubmed CrossRef
  16. DeBourcy, AC, Lichtenberger, S, Felton, S, Butterfield, KT, Ahnen, DJ, and Denberg, TD (2008). Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 23, 169-174.
    CrossRef
  17. Wolf, RL, Basch, CE, Brouse, CH, Shmukler, C, and Shea, S (2006). Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health. 96, 809-811.
    Pubmed KoreaMed CrossRef
  18. Pignone, M, Bucholtz, D, and Harris, R (1999). Patient preferences for colon cancer screening. J Gen Intern Med. 14, 432-437.
    Pubmed KoreaMed CrossRef
  19. Wong, MC, John, GK, and Hirai, HW (2012). Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys. Cancer Causes Control. 23, 1541-1548.
    Pubmed CrossRef
  20. Naing, C, Jun, YK, and Yee, WM (2014). Willingness to take a screening test for colorectal cancer: a community-based survey in Malaysia. Eur J Cancer Prev. 23, 71-75.
    CrossRef
  21. Saengow, U, Chongsuwiwatvong, V, Geater, A, and Birch, S (2015). Preferences and acceptance of colorectal cancer screening in Thailand. Asian Pac J Cancer Prev. 16, 2269-2276.
    Pubmed CrossRef
  22. Wong, MC, Ching, JY, Chan, VC, and Sung, JJ (2015). The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy. Sci Rep. 5, 13568.
    Pubmed KoreaMed CrossRef
  23. Singal, AG, Gupta, S, and Tiro, JA (2016). Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: a randomized controlled trial in a safety-net health system. Cancer. 122, 456-463.
    CrossRef
  24. Quintero, E, Castells, A, and Bujanda, L (2012). Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 366, 697-706.
    Pubmed CrossRef
  25. ClinicalTrials.gov (c2016). CONFIRM trial [Internet].[cited 2016 Dec 19]. Available from: http://www.clinicaltrials.gov/ct2/show/NCT01239082
  26. Kaminski, MF, Bretthauer, M, and Zauber, AG (2012). The NordICC study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy. 44, 695-702.
    Pubmed KoreaMed CrossRef
  27. ClinicalTrials.gov (c2016). SCREESCO trial [Internet].[cited 2016 Dec 19]. Available from: http://www.clinicaltrials.gov/ct2/show/NCT02078804
  28. Brenner, H, Chang-Claude, J, Jansen, L, Knebel, P, Stock, C, and Hoffmeister, M (2014). Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology. 146, 709-717.
    CrossRef
  29. Khalid-de Bakker, C, Jonkers, D, Smits, K, Mesters, I, Masclee, A, and Stockbrügger, R (2011). Participation in colorectal cancer screening trials after first-time invitation: a systematic review. Endoscopy. 43, 1059-1086.
    Pubmed CrossRef
  30. Hummel, JM, Steuten, LG, Groothuis-Oudshoorn, CJ, Mulder, N, and Ijzerman, MJ (2013). Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis. Appl Health Econ Health Policy. 11, 499-507.
    Pubmed CrossRef
Gut and Liver

Vol.19 No.1
January, 2025

pISSN 1976-2283
eISSN 2005-1212

qrcode
qrcode

Supplementary

Share this article on :

  • line

Popular Keywords

Gut and LiverQR code Download
qr-code

Editorial Office